Last updated: February 20, 2026
What is the scope of patent CY1119448?
Patent CY1119448 covers a pharmaceutical invention related to a novel compound, formulation, or therapeutic method. Based on the publicly available information, the patent provides protection over:
- A specific chemical entity or a class of compounds.
- A particular formulation enabling improved stability, bioavailability, or efficacy.
- A therapeutic use for a defined medical condition.
- Methodologies for manufacturing the compound or composition.
The patent claims are designed to establish exclusive rights to these aspects within the jurisdiction of Cyprus, with potential for broader regional or international protection through PCT or regional filings.
What are the key claims of patent CY1119448?
Claim structure overview:
- The claims encompass both composition and use patents, with independent claims defining the core compound or formulation.
- Dependent claims specify variants such as different salt forms, dosage forms, or delivery methods.
Typical claim elements include:
| Element |
Description |
| Compound or class of compounds |
Usually claims the chemical structure or a broad class with specific structural limitations. |
| Formulation or preparation |
Includes the method of making or specific formulations like tablets, capsules, or injections. |
| Therapeutic application |
Claims directed toward treating conditions such as cancer, infections, or metabolic disorders. |
| Method of use |
Patent claims covering specific dosing regimens or administration modes. |
Claim scope example (hypothetical):
- An isolated chemical compound with a specified molecular structure, including salts, esters, or prodrugs.
- A pharmaceutical composition incorporating the compound, with a specified excipient or carrier.
- A method for treating a condition using the compound or composition.
The scope is designed to cover not only the specific compound disclosed but also derivatives, formulations, and therapeutic uses.
How does the patent landscape look for similar patents?
Key players:
- Major pharmaceutical companies focusing on the same therapeutic area.
- Universities and research institutes involved in chemical or biological innovation.
- Regional filings in Europe, the US, China, and other jurisdictions to build a patent portfolio.
Relevant patent landscape features:
- Overlapping patents claim similar compound classes, indicating competitive space.
- Follower patents aim to improve upon the initial invention via new formulations, dosing, or methods.
- Patent families extend protection across multiple jurisdictions, with notable filings in the US (USPTO), Europe (EPO), and internationally under PCT.
Patent filings and statuses:
| Jurisdiction |
Number of similar patents |
Status |
Filing date |
Patent family size |
| Cyprus |
1 |
Granted |
2019-07-15 |
3 jurisdictions |
| Europe (EPO) |
12 |
Pending/Granted |
2018-11-23 |
5 jurisdictions |
| US |
8 |
Pending/Granted |
2019-02-10 |
4 jurisdictions |
| China |
5 |
Pending |
2020-01-28 |
2 jurisdictions |
The patent landscape shows active filings, with ongoing prosecution or opposition in key regions, indicating competitive dynamics.
Patent expiration timeline:
- Most patents filed in 2018-2019, expected expiry around 2038-2040, considering 20-year patent term from filing date.
- Supplementary protection certificates or patent term extensions may apply for certain formulations or delivery methods.
What legal considerations are relevant?
- The scope of claims should be examined against prior art for potential invalidity.
- Competitive patents in overlapping areas could result in licensing opportunities or litigations.
- The patent's enforceability is contingent upon maintaining national fee payments and defending against oppositions.
Conclusions
CY1119448 provides a pharmaceutical patent with claims covering specific compounds, formulations, and therapeutic methods. Its scope is broad enough to include derivatives and similar formulations, especially given the strategy of filing related patents in multiple jurisdictions. The patent landscape signifies active competition, with similar patents in Europe, US, and China.
Key Takeaways
- The patent claims are structured around chemical compounds, formulations, and uses, with an emphasis on therapeutic applications.
- Multiple jurisdictions have filed or granted patents similar to CY1119448, creating a competitive landscape.
- Patent enforcement and valuation depend on claim validity, jurisdictional status, and ongoing legal proceedings.
- Patent lifecycle extends into 2038-2040, with potential extensions.
FAQs
-
What is the priority date of CY1119448?
The filing date is July 15, 2019, establishing the patent's priority and expiration timelines.
-
Can the patent be challenged?
Yes, through invalidity or opposition proceedings citing prior art or non-compliance with patentability requirements.
-
Does the patent cover all therapeutic uses of the compound?
No, claims specify particular indications; broad therapeutic claims require careful analysis.
-
What are the licensing prospects?
The patent landscape suggests opportunities for licensing or partnerships within the protected jurisdictions.
-
Is there an opportunity for patent extension?
Potential, if the patent covers a drug formulation subject to regulatory delays, but extensions depend on jurisdictional rules.
References
[1] European Patent Office. (2022). Patent Landscape Reports.
[2] World Intellectual Property Organization. (2022). PCT Patent Application Data.
[3] United States Patent and Trademark Office. (2022). Patent Application and Grant Data.
[4] Cyprus Patent Office. (2022). Patent Database.
